ASCO 2012 Report – Abiraterone added to pre-surgical regimen helps eliminate prostate tumor in some men with high-risk prostate cancer
by Bruce Sylvester – In a randomized Phase II study presented at ASCO, investigators reported that 6 months of treatment with the targeted drug abiraterone (Zytiga) when added… read more.